AMI ORGANICS
|
AMI ORGANICS Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 11.60 | 22.86 | 19.75 | 17.14 | 26.16 |
| CEPS(Rs) | 17.56 | 26.25 | 22.51 | 6.16 | 9.84 |
| DPS(Rs) | 3.00 | 3.00 | 3.00 | - | - |
| Book NAV/Share(Rs) | 182.13 | 163.01 | 143.34 | 51.03 | 100.85 |
| Tax Rate(%) | 40.53 | 25.75 | 21.33 | 24.72 | 20.96 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 17.91 | 19.88 | 20.22 | 23.53 | 17.12 |
| EBIT Margin(%) | 12.24 | 18.58 | 18.81 | 22.71 | 16.83 |
| Pre Tax Margin(%) | 11.42 | 18.19 | 17.58 | 21.06 | 14.50 |
| PAT Margin (%) | 6.79 | 13.50 | 13.83 | 15.85 | 11.46 |
| Cash Profit Margin (%) | 9.03 | 15.51 | 15.77 | 17.08 | 12.93 |
| Performance Ratios | |||||
| ROA(%) | 5.23 | 11.68 | 13.42 | 16.74 | 12.34 |
| ROE(%) | 7.70 | 14.92 | 21.07 | 40.51 | 29.78 |
| ROCE(%) | 11.81 | 20.45 | 23.85 | 33.43 | 27.09 |
| Asset Turnover(x) | 0.77 | 0.87 | 0.97 | 1.06 | 1.08 |
| Sales/Fixed Asset(x) | 1.80 | 2.33 | 2.40 | 2.27 | 2.54 |
| Working Capital/Sales(x) | 3.41 | 2.10 | 1.73 | 6.79 | 9.07 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.55 | 0.43 | 0.42 | 0.44 | 0.39 |
| Receivable days | 111.06 | 116.58 | 99.79 | 94.89 | 100.90 |
| Inventory Days | 70.18 | 68.46 | 60.54 | 60.39 | 69.31 |
| Payable days | 122.64 | 143.66 | 135.92 | 138.36 | 169.65 |
| Valuation Parameters | |||||
| PER(x) | 94.36 | 38.89 | 50.63 | - | - |
| PCE(x) | 62.32 | 33.87 | 44.41 | - | - |
| Price/Book(x) | 6.01 | 5.45 | 6.97 | - | - |
| Yield(%) | 0.27 | 0.34 | 0.30 | - | - |
| EV/Net Sales(x) | 5.85 | 5.16 | 6.81 | 0.49 | 0.28 |
| EV/Core EBITDA(x) | 30.88 | 25.09 | 32.83 | 2.03 | 1.51 |
| EV/EBIT(x) | 47.81 | 27.79 | 36.21 | 2.14 | 1.64 |
| EV/CE(x) | 4.71 | 5.33 | 5.38 | 0.40 | 0.29 |
| M Cap / Sales | 5.63 | 5.25 | 7.00 | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 16.33 | 18.57 | 52.71 | 42.13 | 0.47 |
| Core EBITDA Growth(%) | 7.13 | 17.59 | 32.39 | 85.90 | 3.29 |
| EBIT Growth(%) | -23.34 | 17.09 | 26.52 | 91.73 | 1.20 |
| PAT Growth(%) | -41.52 | 15.77 | 33.24 | 96.57 | 17.92 |
| EPS Growth(%) | -49.26 | 15.77 | 15.18 | -34.48 | 17.92 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.32 | 0.01 | - | 0.85 | 0.56 |
| Current Ratio(x) | 1.74 | 2.81 | 3.32 | 1.30 | 1.28 |
| Quick Ratio(x) | 1.19 | 2.08 | 2.45 | 0.94 | 0.73 |
| Interest Cover(x) | 14.79 | 47.50 | 15.27 | 13.77 | 7.22 |
| Total Debt/Mcap(x) | 0.05 | - | - | - | - |
Compare Financial Ratios of peers of AMI ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMI ORGANICS | ₹8,590.6 Cr | -6.9% | -7.1% | 85.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹450,595.0 Cr | 0.9% | 4.4% | 50% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,089.0 Cr | 4.6% | -1.1% | 55.6% | Stock Analytics | |
| CIPLA | ₹124,175.0 Cr | 2.1% | 0.2% | 22.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,625.0 Cr | -1.1% | 12.1% | 18.1% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹99,672.5 Cr | 1.8% | 0.9% | 41.3% | Stock Analytics | |
AMI ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMI ORGANICS | -6.9% |
-7.1% |
85.5% |
| SENSEX | 1.9% |
-0.4% |
10.4% |
You may also like the below Video Courses
